Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...

PHM continues to advance with diverse research impacting clinical care, quality improvement, and health equity. The top 10 ...

ROCHESTER HILLS, Mich. - Wrangling three children with autism consumed Dana Paduchowski’s days in a chaotic swirl, her weeks ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Invasive fungal infections rates are rising due to expanding immunocompromised populations and the use of immunosuppressive ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $8.3 million ...

The Children's Dream Foundation (CDF) recently announced its 2025 grant awards to support the ever-growing medical needs of children in ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a ...

Michael Fraley breaks down what paramedics need to know about what’s changed — and what hasn’t — in the new resuscitation ...

By age group, the pediatric segment is expected to grow at the fastest ... they are exploring safer and more convenient ...